Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Irreversible inactivators of EGF receptor TK hold promise as antitumor agents

Nov. 5, 1998

NAALADase inhibitors now reported to be useful for prostate cancer; patents issued

Nov. 3, 1998

Mitomycin C derivative shows therapeutic potential in treating bladder carcinoma

Nov. 3, 1998

Impressive results obtained with C225 in combination with radiotherapy in head and neck cancer

Nov. 3, 1998

Oncocidin A1: a novel microtubule-binding antitumor agent

Nov. 2, 1998

FDA approves Nolvadex for prevention of breast cancer

Oct. 30, 1998

FDA Oncologic Drugs Advisory Committee meets for two days in November

Oct. 30, 1998

Successful completion of phase I/II clinical trial of VIMRxyn in brain cancer

Oct. 30, 1998

Camptothecin analogues and prodrugs described in patent literature by SCRAS

Oct. 30, 1998

Vitamin D analogue Ro-25-9716 potentially useful in treating myeloid leukemia

Oct. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...